Type 1 · Individual ✓ Active NPI ✓ Valid NPI checksum

Jonathan Mark Bridges, MD

Hematology & Oncology Physician in Birmingham, AL · enumerated 2007 · practices at Hematology and Oncology Associates of Alabama, LLC.

Data current as of Jul 13, 2026 · sourced from CMS NPPES

National Provider Identifier

1598979973

Verified

See something wrong? Report a correction

Registry record

Entity type Individual (Type 1)

Name Jonathan Mark Bridges

Credential MD

Sex Male

Practice address 513 Brookwood Blvd Ste 275, Birmingham, AL, 35209

Phone (205) 502-4700

Fax (877) 353-3589

Enumeration date May 9, 2007

Last updated in NPPES May 4, 2026

Taxonomy & licenses

207RH0003X Hematology & Oncology Physician Allopathic & Osteopathic Physicians · License 26776 (AL) Primary

MD · Doctor of Medicine: A physician who completed medical school (allopathic medicine), residency training, and state licensure. About the MD credential

Other identifiers

Identifier	Type	State	Issuer
510-12252	Other	AL	BLUECROSS BLUESHIELD (SYLACAUGA)
1598979973	Medicaid	AL	-
510-12242	Other	AL	BLUECROSS BLUESHIELD (BIRMINGHAM)

What is an NPI number?

A National Provider Identifier (NPI) is a unique 10-digit number that CMS assigns to every U.S. healthcare provider and organization under HIPAA. Type 1 NPIs identify individual providers; Type 2 NPIs identify organizations. The NPI appears on insurance claims, prescriptions, and credentialing paperwork, and never changes, even if the provider moves or changes specialty.

Read the full guide → Validate an NPI →

Frequently asked questions

Is NPI 1598979973 active?

Yes, as of the latest NPPES snapshot, NPI 1598979973 is active (record last updated 2026-05-04).

How do I verify Jonathan Bridges's NPI record?

Cross-check NPI 1598979973 against the official CMS registry at npiregistry.cms.hhs.gov. This page mirrors the same public NPPES data with a monthly snapshot.

Other providers at this practice address

Browse all →

Source: CMS NPPES (public data). Snapshot 2026-07-13. Provider record last updated 2026-05-04.